VIEKIRA PAK (COPACKAGED)

PeakSM

dasabuvir sodium; ombitasvir, paritaprevir, ritonavir

AbbVie
NDAORALTABLETPriority Review
Approved
Dec 2014
Lifecycle
Peak
Competitive Pressure
0/100

Loss of Exclusivity

LOE Date
Oct 18, 2033
92 months away
Patent Expiry
Oct 18, 2033

Patent Records (5)

Patent #ExpiryTypeUse Code
9139536
Nov 9, 2028
U-1753
8501238
Dec 19, 2028
SubstanceProduct
U-1636
8188104
May 17, 2029
SubstanceProduct
U-1636
8642538
Sep 10, 2029
SubstanceProduct
U-1638
9006387
Jun 10, 2030
U-1687
Company
AbbVie
AbbVie
NORTH CHICAGO, IL
1495 open jobs
External Resources
FDA Drugs@FDA
FDA approval history